Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Cologne
Clinical trial register · Germany

Clinical Trials in Cologne, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5087 matching records held by the registry are in this view. Synced 20 Nov 2026, 03:18 UTC
5087
Studies in scope
all four open statuses
2894
Recruiting now
open to new participants
991
Lead sponsors
across recruiting studies
Top sites
Berlin 32 Dresden 15 Frankfurt 14 Leipzig 13 Hamburg 12
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca49 Novartis Pharmaceuticals28 University of Cologne25 Bristol-Myers Squibb22 Janssen Research & Development, LLC21 Eli Lilly and Company21 Boehringer Ingelheim16 Hoffmann-La Roche13 Amgen12 Merck Sharp & Dohme LLC12 GlaxoSmithKline11 AbbVie11 Gilead Sciences10 University Hospital of Cologne9 Boston Scientific Corporation8 Abbott Medical Devices6 Edwards Lifesciences6 German CLL Study Group6 Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest6 Bayer5 Technische Universität Dresden5 Heinrich-Heine University, Duesseldorf5 BeOne Medicines5 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company5 German Cancer Research Center4 Medtronic4 LMU Klinikum4 European Organisation for Research and Treatment of Cancer - EORTC4 Celgene4 BioMarin Pharmaceutical3 Universitätsklinikum Hamburg-Eppendorf3 University of Oxford3 Janssen Pharmaceutica N.V., Belgium3 Vertex Pharmaceuticals Incorporated3 Mirati Therapeutics Inc.3 Daiichi Sankyo3 Alnylam Pharmaceuticals3 Genmab3 Pfizer3 Sanofi3 Novo Nordisk A/S3 Incyte Corporation3 ViiV Healthcare3 Takeda3 BioNTech SE3 Alexion Pharmaceuticals, Inc.3 Nuvalent Inc.2 Goethe University2 Revolution Medicines, Inc.2 Ascendis Pharma A/S2 argenx2 Universität Münster2 Universitätsklinikum Köln2 UMC Utrecht2 Evangelic Hospital Kalk Cologne2 Oliver Cornely, MD2 Leipzig Heart Science gGmbH2 University Hospital Heidelberg2 Cardiovalve Ltd.2 Medtronic Cardiovascular2 EyePoint Pharmaceuticals, Inc.2 Heidelberg University2 University Hospital Tuebingen2 Otsuka Pharmaceutical Development & Commercialization, Inc.2 Swedish Orphan Biovitrum2 Asklepios proresearch2 CVRx, Inc.2 Copenhagen University Hospital, Rigshospitalet2 GBG Forschungs GmbH2 Kailera2 Ionis Pharmaceuticals, Inc.2 iVascular S.L.U.2 Basilea Pharmaceutica2 Miltenyi Biomedicine GmbH2 IntraBio Inc2 Corvia Medical2 Technical University of Munich2 UCB Biopharma SRL2 CRISPR Therapeutics1 Zenas BioPharma (USA), LLC1 Bolt Medical1 University of Leipzig1 Hannover Medical School1 Stichting European Myeloma Network1 ADARx Pharmaceuticals, Inc.1 Immutep S.A.S.1 Tesaro, Inc.1 Zai Lab (Shanghai) Co., Ltd.1 Stefan Hagel1 Dren Bio1 University of Kiel1 University of Milano Bicocca1 SpectraCure AB1 Stemline Therapeutics, Inc.1 Alliance Foundation Trials, LLC.1 iSTAR Medical1 Vifor Fresenius Medical Care Renal Pharma1 NovoCure Ltd.1 Regeneron Pharmaceuticals1 enGene, Inc.1 National Cancer Institute (NCI)1 Kyowa Kirin Pharmaceutical Development Ltd1 Medical University of Graz1 Population Health Research Institute1 Mundipharma Research Limited1 D3 Bio (Wuxi) Co., Ltd1 Nikolaj Frost MD1 Cardiovascular and Interventional Radiological Society of Europe1 University Hospital Goettingen1 Corbus Pharmaceuticals Inc.1 Aragon Pharmaceuticals, Inc.1 Pierre Fabre Medicament1 Xeltis1 Shanghai Henlius Biotech1 Razor Genomics1 University Eye Hospital, Freiburg1 LivaNova1 medac GmbH1 Swiss GO Trial Group1 Hamilton Health Sciences Corporation1 AvenCell Europe GmbH1 Liquidia Technologies, Inc.1 Ellipses Pharma1 Nova Eye, Inc.1 Ultragenyx Pharmaceutical Inc1 Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia1 Alentis Therapeutics AG1 Philipps University Marburg1 Crinetics Pharmaceuticals Inc.1 The University of Texas Health Science Center, Houston1 CRISPR Therapeutics AG1 IDEAYA Biosciences1 Turning Point Therapeutics, Inc.1 Endotronix, Inc.1 Penumbra Inc.1 Heidelberg Pharma AG1 HUYABIO International, LLC.1 Universitaire Ziekenhuizen KU Leuven1 Women's Cancer Study Group GmbH1 IHF GmbH - Institut für Herzinfarktforschung1 4C Medical Technologies, Inc.1 Dominik Paul Modest1 Frank G. Holz1 IlluminOss Medical, Inc.1 Viatris Innovation GmbH1 Maastricht University1 Dompé Farmaceutici S.p.A1 Maastricht University Medical Center1 The Leeds Teaching Hospitals NHS Trust1 Merit Medical Systems, Inc.1 Annetine Gelijns1 German Society for Pediatric Oncology and Hematology GPOH gGmbH1 Montefiore Medical Center1 Occlutech International AB1 RECORDATI GROUP1 Genentech, Inc.1 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 Boris Böll1 JOTEC GmbH1 USWM CT, LLC1 DKMS gemeinnützige GmbH1 Radboud University Medical Center1 Prof. Dr. Paul Brinkkoetter1 North Eastern German Society of Gynaecological Oncology1 Euresist Network GEIE1 JenaValve Technology, Inc.1 University of Regensburg1 Central Institute of Mental Health, Mannheim1 University Hospital, Grenoble1 Ottawa Heart Institute Research Corporation1 Nationwide Children's Hospital1 University Medical Center Groningen1 Medtronic Cardiac Surgery1 Prof. Dr. Juergen Wolf1 Innovacell GmbH1 Universität Duisburg-Essen1 Steffen Paschen1 Casper Rokx1 DualityBio Inc.1 Artcline GmbH1 Vedanta Biosciences, Inc.1 Acumen Pharmaceuticals1 Inmunova S.A.1 MedSIR1 Loxo Oncology, Inc.1 Rotkreuzklinikum München gGmbH1 Indiana University1 Medstar Health Research Institute1 Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 Stephan Baldus1 Atrial Fibrillation Network1 Calico Life Sciences LLC1 University of Pittsburgh1 Martin Schrappe1 Stephanie Mehl1 Gustave Roussy, Cancer Campus, Grand Paris1 Medtronic Cardiac Ablation Solutions1 Immatics US, Inc.1 Global Coalition for Adaptive Research1 OncoZenge AB1 University Medicine Greifswald1 Kite, A Gilead Company1 Intuitive Surgical1 CatalYm GmbH1 Stichting Hemato-Oncologie voor Volwassenen Nederland1 University Hospital, Basel, Switzerland1 Prof. Arasch Wafaisade1 Travere Therapeutics, Inc.1 Profound Medical Inc.1 M.A. Med Alliance S.A.1 NSC-Therapeutics1 Dimerix Bioscience Pty Ltd1 Brigham and Women's Hospital1 Gossamer Bio USA, Inc.1 Matthias Stuber1 BioNTech Cell & Gene Therapies GmbH1 Novian Health Inc.1 University of Minnesota1 PDC*line Pharma SAS1 University Hospital, Bonn1 Ipsen1 Taiho Oncology, Inc.1 Jazz Pharmaceuticals1 CarThera1 Rolfs Consulting und Verwaltungs-GmbH (RCV)1 Acandis GmbH1 SystImmune Inc.1 Assistance Publique - Hôpitaux de Paris1 University of Dublin, Trinity College1 BioLineRx, Ltd.1 Biotronik SE & Co. KG1 ReCor Medical, Inc.1 Prof. Dr. Hartmut Goldschmidt1 Ursula Werra1 OmniVision GmbH1 Claus Cursiefen1 Beeline Medicines Corporation1 Britannia Pharmaceuticals Ltd.1 Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1 Biogen1 Clear sponsor filter
Target enrolment
to

Trials with a site in Cologne

3 of 5087 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
Sanofi
Phase 2
160
Berlin, Cologne
2026-07-28
Active, closed
Sanofi
Phase 3
260
Berlin, Cologne, Dresden, Freiburg im Breisgau, Hamburg, Kiel, Münster, Regensburg
2024-01-23
Active, closed
Sanofi
Observational
572
Aachen, Ahaus, Andernach, Berlin, Braunschweig, Buxtehude, Chemnitz, Cologne
2023-03-07
Rows per page Showing 1–3 of 3
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-germany/city/cologne

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,087 studies in total at the last sync on 20 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3 of those studies with a site in Cologne that also match the filters currently applied.

How many clinical trials are recruiting in Cologne?

1 of the 3 studies on this page are recruiting new participants as of the 20 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Cologne), 3 studies
PhaseStudiesRecruitingShare
Observational1033.3%
Phase 21133.3%
Phase 31033.3%

Most active sponsors

Lead sponsors with the most studies (Cologne)
Lead sponsorStudiesRecruiting
Sanofi31
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.